Real-world efficacy and safety of nebivolol in Korean patients with hypertension from the BENEFIT KOREA study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world efficacy and safety of nebivolol in Korean patients with hypertension from the BENEFIT KOREA study

Published:2020-03 Issue:3 Volume:38 Page:527-535
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Shin Jinho,Choi Yu Jeong,Hong Geu-Ru,Jeon Dong Woon,Kim Dae-Hyeok,Koh Young Youp,Mancia Giuseppe,Manolis Athanasios J.,Yoon Hyuck-Jun,Park Sang Won

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference56 articles.

1. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015;Lancet,2016

2. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg, 1990-2015;Forouzanfar;JAMA,2017

3. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis 1479 population-based measurement studies with 19.1 million participants;Lancet,2017

4. Hypertension treatment in the Asia-Pacific: the role of and treatment strategies with nebivolol;Kim;Heart Asia,2016

5. Korea hypertension fact sheet 2018;Kim;Clin Hypertens,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta-Blockers for Hypertension in Asian Population;Hypertension and Cardiovascular Disease in Asia;2022

2. Compelling Indications Should be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class;Current Vascular Pharmacology;2021-03-23

3. Efficacy and safety of nebivolol in Korean patients with hypertension by age and sex: a subanalysis from the BENEFIT-KOREA study;Clinical Hypertension;2021-03-15

4. May we apply results data from classical hypertension clinical trials to all beta-blockers?;Journal of Hypertension;2020-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3